Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 2,903 | 1,836 | 1,984 | 1,819 | 1,431 |
| Operating Income | -2,903 | -1,836 | -1,984 | -1,819 | -1,431 |
| Other Income | 61 | 140 | -18 | 9 | -12 |
| Pre-tax Income | -2,842 | -1,697 | -2,002 | -1,811 | -1,443 |
| Net Income Continuous | -2,842 | -1,697 | -2,002 | -1,811 | -1,443 |
| Net Income | $-2,842 | $-1,697 | $-2,002 | $-1,811 | $-1,443 |
| EPS Basic Total Ops | -0.06 | -0.04 | -0.05 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.06 | -0.04 | -0.06 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -0.06 | -0.04 | -0.05 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.06 | -0.04 | -0.06 | -0.05 | -0.05 |
| EBITDA(a) | $-2,896 | $-1,829 | $-1,980 | $-1,819 | $-1,430 |